Skip To Main Content
Influenza hero banner

Seasonal influenza is an acute respiratory infection caused by influenza viruses which circulate in all parts of the world. It spreads easily, with rapid transmission in crowded areas including schools.

 

SYMPTOMS

Seasonal influenza is characterized by a sudden onset of fever, cough (usually dry), headache, muscle and joint pain, severe malaise (feeling unwell), sore throat and a runny nose. The cough can be severe and can last 2 or more weeks.

Most people recover from fever and other symptoms within a week without requiring medical attention. But influenza can cause severe illness or death especially in people at high risk.

 

DIAGNOSTIC

The majority of cases of human influenza are clinically diagnosed.

Collection of appropriate respiratory samples and the application of a laboratory diagnostic test is required to establish a definitive diagnosis. Proper collection, storage and transport of respiratory specimens is the essential first step for laboratory detection of influenza virus infections.

Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).

 

PREVENTION

The most effective way to prevent the disease is vaccination.

 

EPIDEMIOLOGY

Seasonal influenza represents a year-round disease burden. It causes illnesses that range in severity and sometimes lead to hospitalization and death.

Worldwide, these annual epidemics are estimated to result in about 3 to 5 million cases of severe illness, and about 290,000 to 650,000 respiratory deaths.

 

 

REFERENCES
 

  1. Warren-Gash C, et al. (2018) Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland. Eur Resp J 51:1701794; DOI: 10.1183/13993003.01794-2017 
    Date Accessed: June 30, 2023

  2. Kubale J, et al. (2021) Individual-level association of influenza infection with subsequent pneumonia: a case-control and prospective cohort study. Clin Infect Dis 73:e4288-e4295; DOI: 10.1093/cid/ciaa1053
    Date Accessed: June 30, 2023

  3. WHO Influenza Fact Sheet. https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)
    Date Accessed: June 30, 2023

Frequently Asked Questions

COMING SOON

Browse through medical articles

COMING SOON

Browse through on-demand medical videos

From Lab to Jab: The Journey of Vaccine Creation

March 2025

Sanofi has been committed to developing and delivering innovative vaccines for over 100 years, contributing to global health protection.

Watch video

Dyad Protection against Influenza

May 2024

Influenza Vaccination in Pregnancy

Watch video

Panel Discussion on Vaccination and the Philippine Health Systems

February 2024

RealTALK: Vaccine Expert Dr. Rontgene Solante

Watch video

Impact of Flu on Cardio

June 2023

How does influenza lead to an increase of cardiovascular events?

Watch video

Influenza Vaccination After Myocardial Infarction (IAMI)

December 2023

Are you aware that contracting the flu may heighten your chances of experiencing a heart attack?

Watch video

Listen through medical discussions

COMING SOON

Browse through different medical cources

COMING SOON

Explore upcoming medical events

Switch-Off Webinar Invite

Safeguarding High-Risk Groups: The Importance of Flu Vaccination and Effective Communication

April 2025

Webinar discussion on the importance of flu vaccination and effective communication

Join event
Vaccination in Pregnancy Webinar Invite

Vaccination in Pregnancy: An Essential Component of Antenatal Care

April 2025

Webinar discussion on Vaccination in Pregnancy: an essential component of antenatal care

Join event

Explore downloadable medical resources

PDF Document
Protection beyond Flu: 2024 June Issue
PDF Document
Protection beyond Flu: 2024 May Issue
PDF Document
Protection beyond Flu: 2024 April Issue
PDF Document
Protection beyond Flu: 2024 March Issue
PDF Document
Protection beyond Flu: 2024 February Issue

Adverse events & product safety

 
Adverse events & product safety

If you experience any adverse event, i.e., anu unfavorable and unintended sign (an abnormal laboratory finding), symptom, or disease temporarily associated with the use of a medical product, please email it to PV.Philippines@sanofi.com 
 

For Data Privacy requests and concerns:
 

Sanofi General Medicines (under sanofi-aventis Philippines, Inc.)
Data Privacy: privacy.PH@sanofi.com
 
Sanofi Vaccines (under Sanofi Pasteur, Inc.)
 
For Data subject requests both:
Sanofi General Medicines (under sanofi-aventis Philippines, Inc.) and Sanofi Vaccines (under Sanofi Pasteur, Inc.): OneTrust